ilmscore | Why did Sun Pharma fall by 4%? #shorts

Why did Sun Pharma fall by 4%? #shorts

Published: 2024-11-04
Status: Analyzed

Predictions from this Video

Total: 2
Correct: 0
Incorrect: 0
Pending: 2
Prediction
Topic
Status
Sun Pharma's Lavi tablet launch in the US is predicted to be delayed until December 2026 due to patent expiration.
"the company won't be able to launch the drug until December 2026, when the US company Incyte's patent expires."
Sun Pharma's Lavi tablet launch
Pending
Sun Pharma's near-term earnings are predicted to be negatively impacted by 3% to 6% if a settlement with Incyte is not reached.
"Sun Pharma's near-term earnings could be impacted by 3 to 6 percent."
Sun Pharma earnings
Pending